Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 9,301 filings

Top spenders & firms Spend by issue

Clear
Q3
FEDERAL HEALTH POLICY STRATEGIES for NATIONAL ALLIANCE FOR CARE AT HOME
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $60,000.00 income
Medicare/Medicaid
View →
Q3
THE ACADEMY ADVISORS, INC. for THE ACADEMY ADVISORS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Health Issues, Medicare/Medicaid
View →
Q3
HOLLAND & KNIGHT LLP for DENVER HEALTH AND HOSPITAL AUTHORITY
3rd Quarter (July 1 - Sep 30) 2025 · Colorado · House · Senate · $40,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
ALSTON & BIRD LLP for AMERICAN COLLEGE OF RADIOLOGY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $10,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for KIDNEY CARE PARTNERS
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $80,000.00 income
Medicare/Medicaid, Health Issues
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for SCULLY ROSKEY AND MISSMAR ON BEHALF OF ENCOMPASS HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $20,000.00 income
Medicare/Medicaid
View →
Q3
LIVANOVA USA, INC. for LIVANOVA USA, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate
Medicare/Medicaid, Health Issues
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for UPMC
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for UPMC HEALTH PLAN
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
ALSTON & BIRD LLP for AMERICAN COLLEGE OF OSTEOPATHIC FAMILY PHYSICIANS
3rd Quarter (July 1 - Sep 30) 2025 · Illinois
Health Issues, Medicare/Medicaid
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for FRESENIUS MEDICAL CARE NORTH AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q3
ALSTON & BIRD LLP for AMERICAN COLLEGE OF LIFESTYLE MEDICINE
3rd Quarter (July 1 - Sep 30) 2025 · Missouri · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for SCAN HEALTH PLAN
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q3
AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Health Issues, Medicare/Medicaid, Homeland Security, Budget/Appropriations
View →
Q3
LMH STRATEGIC SOLUTIONS for REGENXBIO INC.
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for NEUROPACE, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q3
ALSTON & BIRD LLP for AMERICAN COLLEGE OF GASTROENTEROLOGY
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Budget/Appropriations
View →
Q3
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $70,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for ARDELYX, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for ALNYLAM PHARMACEUTICALS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $70,000.00 income
Medicare/Medicaid
View →
Previous Page 192 of 373 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem